BiosimilarsCME.org

System Maintenance Alert

Our website will be temporarily unavailable beginning at 8:00 PM ET today, October 29, for scheduled maintenance. We apologize for any inconvenience this may cause and appreciate your understanding.

Microlearning

Search

Filter Content

BiosimilarsCME.org offers educational opportunities and resources to help clinicians improve their knowledge and competence in the use of biosimilars across multiple therapeutic areas.

Results 1 - 29 of 29

Biosimilars: Applying the Science to Hematology/Oncology Practice

biosims-archmed icon23

Top Questions about Biosimilars in Dermatology

biosims-archmed icon1

Top Questions about Biosimilars in Gastroenterology

biosims-archmed icon2

Top Questions about Biosimilars in Rheumatology

biosims-archmed icon

Top Questions about Biosimilars in Hematology/Oncology

biosims-gastro2

Biosimilars and Patients with Inflammatory Bowel Disease

biosims-gastro1

Biosimilars: The New Era of Gastroenterology Management Considerations

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Are You Ready to Use Biosimilars in Your Practice?

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation